GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroTech Ltd (HKSE:02172) » Definitions » Earnings Yield (Joel Greenblatt) %

MicroPort NeuroTech (HKSE:02172) Earnings Yield (Joel Greenblatt) % : 2.97% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroTech Earnings Yield (Joel Greenblatt) %?

MicroPort NeuroTech's Enterprise Value for the quarter that ended in Dec. 2023 was HK$6,103.0 Mil. MicroPort NeuroTech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$181.0 Mil. MicroPort NeuroTech's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was 2.97%.

The historical rank and industry rank for MicroPort NeuroTech's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

HKSE:02172' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 0.65   Med: 1.82   Max: 4.83
Current: 4.41

During the past 5 years, the highest Earnings Yield (Joel Greenblatt) of MicroPort NeuroTech was 4.83%. The lowest was 0.65%. And the median was 1.82%.

HKSE:02172's Earnings Yield (Joel Greenblatt) % is ranked better than
73.56% of 851 companies
in the Medical Devices & Instruments industry
Industry Median: 0 vs HKSE:02172: 4.41

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. MicroPort NeuroTech's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


MicroPort NeuroTech Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for MicroPort NeuroTech's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroTech Earnings Yield (Joel Greenblatt) % Chart

MicroPort NeuroTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Earnings Yield (Joel Greenblatt) %
- - - 0.86 2.97

MicroPort NeuroTech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial - - 0.86 - 2.97

Competitive Comparison of MicroPort NeuroTech's Earnings Yield (Joel Greenblatt) %

For the Medical Devices subindustry, MicroPort NeuroTech's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort NeuroTech's Earnings Yield (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroTech's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where MicroPort NeuroTech's Earnings Yield (Joel Greenblatt) % falls into.



MicroPort NeuroTech Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

MicroPort NeuroTechs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=181.032/6102.95492
=2.97 %

For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.



MicroPort NeuroTech  (HKSE:02172) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


MicroPort NeuroTech Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroTech's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort NeuroTech (HKSE:02172) Business Description

Traded in Other Exchanges
N/A
Address
No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN
MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing innovative solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.
Executives
Hu Yibin
Biolink Biomedical Ltd. 2201 Interest of corporation controlled by you
Blossom Vision Limited 2201 Interest of corporation controlled by you
Lion Fish Limited 2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited 2301 Trustee
Thriving Hope Limited 2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership 2201 Interest of corporation controlled by you
Biolink Limited 2101 Beneficial owner
Microport Scientific Corporation
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroTech (HKSE:02172) Headlines

No Headlines